Stock 300254 SHANXI C&Y PHARMACEUTICAL GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company ShanXi C&Y Pharmaceutical Group Co.,LTD.

Equities

300254

CNE1000016D0

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 15/05/2024 BST 		5-day change 1st Jan Change
9.55 CNY +2.80% Intraday chart for ShanXi C&Y Pharmaceutical Group Co.,LTD. -5.63% -0.83%
04-12 ShanXi C&Y Pharmaceutical Group Co.,LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-18 ShanXi C&Y Pharmaceutical Group Co.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

ShanXi C&Y Pharmaceutical Group Co., Ltd. is principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Company’s main products include anti-infective agents, respiratory system agents, cardiovascular drugs, antidepressant drugs, urinary system agents, pediatric agents and other drugs, as well as pharmaceutical raw materials and pharmaceutical intermediates. It also involves in the manufacture and distribution of health food products, as well as the provision of deoxyribonucleic acid (DNA) genetic preservation and pregnant environment testing services. The Company distributes its products in domestic market.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Anti-infective Drugs
22.2 %
173 20.9 % 177 22.2 % +2.23%
Urinary System Drugs
20.7 %
129 15.5 % 165 20.7 % +28.39%
Other Medicines
17.0 %
119 14.4 % 136 17.0 % +13.61%
Pediatric Use
8.4 %
70 8.4 % 67 8.4 % -3.42%
Anti-allergy
8.3 %
166 20.1 % 66 8.3 % -60.22%
Respiratory Medicine
7.2 %
39 4.7 % 58 7.2 % +47.77%
Pharmaceutical Raw Materials and Intermediates
7.1 %
46 5.6 % 57 7.1 % +22.82%
Service
3.3 %
34 4.1 % 27 3.3 % -20.84%
Kidney Medicine
3.3 %
37 4.5 % 26 3.3 % -29.20%
Health Food
1.6 %
11 1.3 % 13 1.6 % +16.91%
Other Business
0.9 %
4 0.5 % 7 0.9 % +65.81%
Commercial
0.1 %
0 0.1 % 1 0.1 % +71.18%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
807 97.3 % 799 100.0 % -0.93%
Hong Kong
0.0 %
22 2.7 % 0 0.0 % -99.09%

Managers

Managers TitleAgeSince
Qun Zhao CEO
 Chief Executive Officer 53 28/02/05
Yan Jie He DFI
 Director of Finance/CFO 42 30/11/10
Hai Rong Zhong BRD
 Director/Board Member 65 16/03/15
Jun Xian Yu BRD
 Director/Board Member 57 28/02/05
Xu Hong Zhang BRD
 Director/Board Member 53 28/02/05
Yuan Yuan Xue IRC
 Investor Relations Contact - -
Ying Min Yu PRN
 Corporate Officer/Principal 61 06/07/16

Members of the board

Members of the board TitleAgeSince
Qun Zhao CEO
 Chief Executive Officer 53 28/02/05
Xu Hong Zhang BRD
 Director/Board Member 53 28/02/05
Jun Xian Yu BRD
 Director/Board Member 57 28/02/05
Hai Rong Zhong BRD
 Director/Board Member 65 16/03/15
Hao Gao BRD
 Director/Board Member 54 10/02/20
Le Qun Huang CHM
 Chairman 69 31/01/20
Tao Ju BRD
 Director/Board Member 38 10/02/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 241,618,563 182,672,525 ( 75.60 %) 0 75.60 %

Shareholders

NameEquities%Valuation
China Asset Management Co., Ltd.
0.4606 %
632,700 0.4606 % 786 345 ¥
Western Leadbank Fund Management Co., Ltd
0.2341 %
321,600 0.2341 % 399 697 ¥
Manulife TEDA Fund Management Co., Ltd.
0.0763 %
104,800 0.0763 % 130 250 ¥
Lion Fund Management Co., Ltd.
0.0127 %
17,400 0.0127 % 21 625 ¥
CCB Principal Asset Management Co., Ltd.
0.0119 %
16,400 0.0119 % 20 383 ¥
China Fund Management Co., Ltd.
0.003640 %
5,000 0.003640 % 6 214 ¥
Gfund Management Co., Ltd.
0.000146 %
200 0.000146 % 249 ¥

Company contact information

Shanxi C&Y Pharmaceutical Group Co., Ltd.

1378, Heng'an Street Economic & Technological Dev Zone

037010, Datong

+

http://www.cy-pharm.com
address ShanXi C&Y Pharmaceutical Group Co.,LTD.(300254)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANXI C&Y PHARMACEUTICAL GROUP CO.,LTD. Stock ShanXi C&Y Pharmaceutical Group Co.,LTD.
-0.83% 311M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 709B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.77% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.60% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.07% 334B
ABBVIE INC. Stock AbbVie Inc.
+6.04% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.77% 239B
NOVARTIS AG Stock Novartis AG
+9.13% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-3.97% 203B
AMGEN INC. Stock Amgen Inc.
+9.27% 171B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300254 Stock
  4. Company ShanXi C&Y Pharmaceutical Group Co.,LTD.